Frusemide inhibition of sympathetic vasoconstriction in the rat in situ blood perfused mesentery

Clinical and Experimental Pharmacology & Physiology
S J ArmsworthA J Smith

Abstract

Mesenteric perfusion pressure was measured in the in situ blood-perfused mesentery of anaesthetized rats. Increases in perfusion pressure were produced by mesenteric periarterial electrical stimulation at 3, 6 and 10 Hz before and after the administration of frusemide 5 mg/kg intravenously (i.v.) or vehicle. Loss of volume due to diuresis was prevented by replacement with intravenous saline. Frusemide did not cause any changes in blood pressure or baseline perfusion pressure. Responses to electrical stimulation were inhibited by frusemide (P less than 0.05) but unchanged by vehicle administration. Acute bilateral nephrectomy or treatment with indomethacin (2 mg/kg i.v.) prevented the inhibitory effect of frusemide on responses to sympathetic nerve stimulation. Responses to sympathetic nerve stimulation were potentiated by an infusion of angiotensin II (12 ng/min) into the mesenteric artery. This infusion did not alter either blood pressure or baseline perfusion pressure. Administration of frusemide 5 mg/kg i.v. attenuated the potentiating effect of angiotensin II on vasoconstrictor responses to electrical nerve stimulation. Frusemide may lead to the release of a prostanoid or prostanoid precursor which inhibits vascular constri...Continue Reading

References

May 1, 1979·The American Journal of Physiology·J M PriceY C Fung
May 31, 1969·British Medical Journal·M L BhatiaS B Roy
Jan 1, 1982·Journal of Cardiovascular Pharmacology·R Hatton, D P Clough
Oct 1, 1983·Clinical Science·G D JohnstonM B Finch
May 1, 1984·British Journal of Clinical Pharmacology·I G MackayM L Watson
Oct 1, 1984·British Journal of Pharmacology·J F Gerkens, A J Smith
Nov 1, 1983·Clinical Pharmacology and Therapeutics·T W Wilson
Jan 1, 1983·Clinical and Experimental Hypertension. Part A, Theory and Practice·H A Struyker-BoudierH van Essen
Feb 1, 1981·Prostaglandins and Medicine·J G Gerber, A S Nies
Jan 1, 1981·Clinical and Experimental Hypertension : CHE·D C EikenburgM F Lokhandwala

❮ Previous
Next ❯

Citations

Jun 1, 1988·Clinical and Experimental Pharmacology & Physiology·J F GerkensA J Smith
May 18, 1999·Pharmacology & Toxicology·J S Petersen
Jan 1, 1987·Clinical and Experimental Hypertension. Part A, Theory and Practice·J F GerkensA J Smith
Oct 1, 1991·Prostaglandins, Leukotrienes, and Essential Fatty Acids·P R HoweY Lungershausen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.